Literature DB >> 8548120

Distribution of thrombospondin and integrin alpha V in DCIS, invasive ductal and lobular human breast carcinomas. Analysis by electron microscopy.

C M Serre1, P Clezardin, L Frappart, G Boivin, P D Delmas.   

Abstract

The ultrastructural distribution of thrombospondin (TSP) and its cell surface receptor, integrin alpha V, was studied in two cases of human breast carcinoma: one of ductal carcinoma in situ (DCIS) with an invasive component, and one of invasive lobular carcinoma. In DCIS, moderate immunolabelling for TSP and integrin alpha V was observed in the rough endoplasmic reticulum and at the plasma membrane of intraductal carcinoma cells. TSP was also associated with extracellular matrix collagen fibrils surrounding in situ carcinoma cells. In the invasive part of this ductal carcinoma, most of the malignant cells were negative for TSP, while integrin alpha V was moderately expressed in these cells. In sharp contrast, typical strands of invasive lobular carcinoma cells in "Indian file" showed moderate TSP immunostaining in the rough endoplasmic reticulum and strong immunoreactivity for TSP at the plasma membrane and in the extracellular matrix. Moderate to strong immunoreactivity for integrin alpha V was also observed in invasive lobular carcinoma cells. Because of the role of TSP during cancer cell invasion, the different expression patterns of TSP in invasive ductal versus lobular carcinoma may well reflect biological differences between these two types of breast carcinoma and could account for the peculiar diffuse invasive behaviour of breast lobular carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548120     DOI: 10.1007/bf00199384

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  Extracellular matrix: the thrombospondin family.

Authors:  J Adams; J Lawler
Journal:  Curr Biol       Date:  1993-03       Impact factor: 10.834

2.  Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells. A model to study the different effects of thrombospondin in cell adhesion.

Authors:  P Clezardin; H Jouishomme; P Chavassieux; P J Marie
Journal:  Eur J Biochem       Date:  1989-05-15

Review 3.  Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin.

Authors:  E H Sage; P Bornstein
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

4.  Immunolocalization of matricial components during the early stages of chick embryonic liver development.

Authors:  C M Barioz; P Sengel; J A Grimaud
Journal:  Biol Struct Morphog       Date:  1988

5.  Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.

Authors:  S Y Wong; A T Purdie; P Han
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

6.  Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.

Authors:  G K Koukoulis; I Virtanen; M Korhonen; L Laitinen; V Quaranta; V E Gould
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

7.  Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.

Authors:  B Felding-Habermann; B M Mueller; C A Romerdahl; D A Cheresh
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

8.  Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Authors:  R Moll; M Mitze; U H Frixen; W Birchmeier
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

9.  Localization of thrombospondin, CD36 and CD51 during prenatal development of the human mammary gland.

Authors:  C Péchoux; P Clezardin; R Dante; C M Serre; M Clerget; N Bertin; J Lawler; P D Delmas; J L Vauzelle; L Frappart
Journal:  Differentiation       Date:  1994-08       Impact factor: 3.880

10.  Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains.

Authors:  G Taraboletti; D D Roberts; L A Liotta
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

View more
  6 in total

1.  Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Authors:  A J Rice; M A Steward; C M Quinn
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 2.  Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast.

Authors:  A Rice; C M Quinn
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

3.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

Authors:  Hongjuan Zhao; Anita Langerød; Youngran Ji; Kent W Nowels; Jahn M Nesland; Rob Tibshirani; Ida K Bukholm; Rolf Kåresen; David Botstein; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
Journal:  Mol Biol Cell       Date:  2004-03-19       Impact factor: 4.138

4.  Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer.

Authors:  B Petricevic; D Vrbanec; J Jakic-Razumovic; I Brcic; D Rabic; T Badovinac; E Ozimec; V Bali
Journal:  Med Oncol       Date:  2011-03-13       Impact factor: 3.064

5.  Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma.

Authors:  Lucas A Tomko; Ryan C Hill; Alexander Barrett; Joseph M Szulczewski; Matthew W Conklin; Kevin W Eliceiri; Patricia J Keely; Kirk C Hansen; Suzanne M Ponik
Journal:  Sci Rep       Date:  2018-08-28       Impact factor: 4.379

6.  Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.

Authors:  Shikha Roy; Rakesh Kumar; Vaibhav Mittal; Dinesh Gupta
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.